Inventor

LAZERWITH SCOTT E

US55 patents

⚠️ This page may combine multiple inventors who share the name “LAZERWITH SCOTT E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LAZERWITH SCOTT E

GILEAD SCIENCES INC

Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections

MCL-1 inhibitors

Therapeutic compounds

Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9,-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1&#39;,2&#39;-d]pyrazines and methods for treating viral infections

Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infections

Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]OXAZEPINES and methods for treating viral infections

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

Inhibitors of Flaviviridae viruses

Antiviral compounds

Antiviral compounds

Capsid inhibitors for the treatment of HIV

MCL-1 inhibitors

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

Inhibitors of Flaviviridae viruses

Substituted pyrrolizine compounds and uses thereof

Crystalline forms of (2R,5S,13AR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13A- octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-B] [1,3] oxazepine-10-carboxamide

Substituted pyrrolizine compounds and uses thereof

Substituted pyrrolidines as SYK inhibitors

MCL-1 inhibitors

Capsid inhibitors for the treatment of HIV

Phospholipid compounds and uses thereof

Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

Substituted pyrrolizine compounds and uses thereof

Syk inhibitors

Substituted pyrrolizine compounds and uses thereof

MCL-1 inhibitors

Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infections

Crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide

Phospholipid compounds and uses thereof

Phospholipid compounds and uses thereof

Substituted pyrrolizine compounds and uses thereof

Phospholipid compounds and uses thereof

Phospholipid compounds and uses thereof

Sars-cov2 main protease inhibitors

Thienopyrrole compounds

KRAS G12D modulating compounds

CANALES EDA

2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections

Inhibitors of flaviviridae viruses

Inhibitors of Flaviviridae viruses

Inhibitors of flaviviridae viruses

GUO HONGYAN

Antiviral compounds

Antiviral compounds

Antiviral compounds

GILEAD PHARMASSET LLC

Antiviral compounds

Antiviral compounds

WATKINS WILLIAM J

Inhibitors of flaviviridae viruses

PFIZER

Biaryl ether urea compounds

Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1',2'-d]pyrazines and methods for treating viral infections